Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objectives: PTPN22 is involved in T-cell activation and its R620W single-nucleotide polymorphism (SNP) has been shown to predispose to different autoimmune diseases. The aims of this study were to investigate the role of the PTPN22 R620W SNP in conferring susceptibility to the ANCA-associated vasculitides (AAVs), and to explore potential associations between the PTPN22 genotype and the disease manifestations.
Methods: PTPN22 R620W SNP was genotyped in a cohort of 344 AAV patients [143 with granulomatosis with polyangiitis (Wegener's) (GPA), 102 with microscopic polyangiitis (MPA) and 99 with Churg-Strauss syndrome (CSS)] and in 945 healthy controls.
Results: The frequency of the minor allele (620W) was significantly higher in GPA patients than in controls [P = 0.005, χ(2 )= 7.858, odds ratio (OR) = 1.91], while no statistically significant association was found with MPA or CSS. Among GPA patients, the 620W allele was particularly enriched in ANCA-positive patients as compared with controls (P = 0.00012, χ(2 )= 14.73, OR = 2.31); a particularly marked association was also found with ENT involvement (P = 0.0071, χ(2 )= 7.258, OR = 1.98), lung involvement (P = 0.0060, χ(2 )= 7.541, OR = 2.07) and skin manifestations of all kinds (P = 0.000047, χ(2 )= 16.567, OR = 3.73).
Conclusion: The PTPN22 620W allele confers susceptibility to the development of GPA (but not of MPA or CSS), and particularly of its ANCA-positive subset.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/rheumatology/ker446 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pregnancy-associated thyroid disorders: the role of genetic, epigenetic, and oxidative stress factors.
Rev Endocr Metab Disord
August 2025
Clinical Research Centre, Medical University of Bialystok, Bialystok, 15-276, Poland.
Thyroid inflammation during pregnancy, particularly Hashimoto's thyroiditis (HT) and postpartum thyroiditis (PPT), has a strong genetic and epigenetic basis. Susceptibility to these conditions is associated with specific HLA haplotypes (HLA-DR3, DR4, DR5) and immune-regulatory genes, including CTLA-4, PTPN22, FOXP3, as well as thyroid-specific genes such as TSHR, TG, and TPO. CTLA-4 polymorphism (CT60) is linked to increased thyroid autoantibody production, while PTPN22 R620W variant disrupts immune tolerance, exacerbating autoreactive lymphocyte activation.
View Article and Find Full Text PDFThe protein tyrosine phosphatase Lyp/PTPN22 drives TNFα-induced priming of superoxide anions production by neutrophils and arthritis.
Free Radic Biol Med
February 2025
INSERM-U1149, CNRS-ERL8252, Université de Paris-Cité, Centre de Recherche sur l'Inflammation, Laboratoire d'Excellence Inflamex, DHU FIRE, Faculté de Médecine, Site Xavier Bichat, Paris, France. Electronic address:
Neutrophils are essential for host defense against infections, but they also play a key role in acute and chronic inflammation. The protein tyrosine phosphatase non-receptor type 22 (PTPN22) gene encodes the lymphoid-specific tyrosine phosphatase (Lyp) and a genetic single-nucleotide polymorphism of PTPN22 rs2476601 (R620W) has been associated with several human autoimmune diseases, including rheumatoid arthritis (RA). Here, we investigated the role of Lyp in TNFα-induced priming of neutrophil ROS production and in the development of arthritis using new selective Lyp inhibitors.
View Article and Find Full Text PDFR620W gene editing in T cells enhances low-avidity TCR responses.
Elife
March 2023
Department of Pediatrics and Immunology, University of Washington, Seattle, United States.
A genetic variant in the gene (R620W, rs2476601) is strongly associated with increased risk for multiple autoimmune diseases and linked to altered TCR regulation and T cell activation. Here, we utilize Crispr/Cas9 gene editing with donor DNA repair templates in human cord blood-derived, naive T cells to generate risk edited (620W), non-risk edited (620R), or knockout T cells from the same donor. risk edited cells exhibited increased activation marker expression following non-specific TCR engagement, findings that mimicked KO cells.
View Article and Find Full Text PDFSH3-domain mutations selectively disrupt Csk homodimerization or PTPN22 binding.
Sci Rep
April 2022
Department of Pharmacology, University of Minnesota, Minneapolis, MN, 55455, USA.
The kinase Csk is the primary negative regulator of the Src-family kinases (SFKs, e.g., Lck, Fyn, Lyn, Hck, Fgr, Blk, Yes), phosphorylating a tyrosine on the SFK C-terminal tail that mediates autoinhibition.
View Article and Find Full Text PDFImprovement of Lipoplexes With a Sialic Acid Mimetic to Target the C1858T Variant for Immunotherapy in Endocrine Autoimmunity.
Front Immunol
April 2022
Infectivology and Clinical Trials Research Department, Bambino Gesù Children's Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
Article Synopsis
- The C1858T variant of the protein tyrosine phosphatase N22 gene is linked to autoimmune diseases like Type 1 diabetes and autoimmune thyroiditis, causing a mutation that reduces T cell activation.
- Researchers developed a personalized treatment using liposomes to deliver siRNA that targets this variant allele more effectively when enhanced with a Siglec-10 ligand.
- The modified lipoplexes (LiposiRNA-Sig10L) showed improved inhibition of the variant mRNA and better restored IL-2 secretion in peripheral blood mononuclear cells (PBMC) from patients with heterozygous Type 1 diabetes compared to standard treatments.